精囊镜技术在治疗难治性血精症患者中的临床研究
发布时间：2018-12-13 17:19
【摘要】：目的 探讨经尿道腔镜技术在治疗精囊腺疾病所致难治性血精中的临床效果和优越性。 方法 本研究选择从2012.2-2014.2在中南大学湘雅医院门诊就诊的精囊腺所致难治性血精疾病患者50例,按患者主观要求分为手术治疗组和保守治疗组。并分别在治疗前和治疗后第1、3、6、12个月,记录精液中的白细胞、红细胞计数、主观血精发生率和生活质量评分；采用SPSS21.0for windows统计软件进行分析,检验比较每组治疗前后的情况,以P0.05为有统计学意义。 结果 1.两组患者治疗后3、6月与治疗前的各项主、客观指标相比均有显著性(P0.05),而手术治疗组在治疗后1年与治疗后6月的各项主、客观指标不具有显著性(P0.05)。 2.在治疗后3、6、12月各项主、客观指标改善程度方面手术组明显优越于保守治疗组,且差异有统计学意义(P0.05)。而两组在治疗后1月的主、客观指标改善程度差异不显著(P0.05)。 结论 1.经尿道精囊镜手术和保守综合治疗均能对由精囊腺疾病所致的难治性血精症状的患者有一定程度的治疗及改善症状的作用。 2.就整体效果而言,经尿道精囊镜手术要明显优于保守综合治疗,可作为单纯药物改善不佳时的一种很好的补充治疗手段。
[Abstract]:Objective to investigate the clinical effect and superiority of transurethral endoscopic technique in the treatment of intractable hemospermia caused by seminal vesicle gland disease. Methods 50 patients with intractable hemospermia caused by seminal vesicle in Xiangya Hospital of Central South University from February to April 2012.were divided into surgical treatment group and conservative treatment group according to the subjective requirements of the patients. The white blood cells (WBC), red blood cell count (RBC), subjective blood spermatozoa incidence and quality of life (QOL) were recorded before and 6 and 12 months after treatment. SPSS21.0for windows statistical software was used to analyze and compare the status of each group before and after treatment, with P0.05 as statistical significance. Result 1. There were significant differences in subjective and objective indexes between 3 and 6 months after treatment in both groups (P0.05), but there was no significant difference in subjective and objective indexes in surgical treatment group in 1 year after treatment and 6 months after treatment (P0.05). 2. The degree of improvement of subjective and objective indexes in the operation group was significantly better than that in the conservative treatment group after 3 months and 12 months, and the difference was statistically significant (P0.05). There was no significant difference in the improvement of subjective and objective indexes between the two groups in 1 month after treatment (P0.05). Conclusion 1. Both transurethral seminal vesicle surgery and conservative comprehensive therapy can treat and improve the symptoms of intractable hemospermia caused by seminal vesicle diseases to a certain extent. 2. As far as the overall effect is concerned, transurethral seminal vesicle surgery is superior to conservative comprehensive therapy, and can be used as a good supplementary treatment for the poor improvement of simple drugs.
【学位授予单位】：中南大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：R697.4
本文编号：2376914
[Abstract]:Objective to investigate the clinical effect and superiority of transurethral endoscopic technique in the treatment of intractable hemospermia caused by seminal vesicle gland disease. Methods 50 patients with intractable hemospermia caused by seminal vesicle in Xiangya Hospital of Central South University from February to April 2012.were divided into surgical treatment group and conservative treatment group according to the subjective requirements of the patients. The white blood cells (WBC), red blood cell count (RBC), subjective blood spermatozoa incidence and quality of life (QOL) were recorded before and 6 and 12 months after treatment. SPSS21.0for windows statistical software was used to analyze and compare the status of each group before and after treatment, with P0.05 as statistical significance. Result 1. There were significant differences in subjective and objective indexes between 3 and 6 months after treatment in both groups (P0.05), but there was no significant difference in subjective and objective indexes in surgical treatment group in 1 year after treatment and 6 months after treatment (P0.05). 2. The degree of improvement of subjective and objective indexes in the operation group was significantly better than that in the conservative treatment group after 3 months and 12 months, and the difference was statistically significant (P0.05). There was no significant difference in the improvement of subjective and objective indexes between the two groups in 1 month after treatment (P0.05). Conclusion 1. Both transurethral seminal vesicle surgery and conservative comprehensive therapy can treat and improve the symptoms of intractable hemospermia caused by seminal vesicle diseases to a certain extent. 2. As far as the overall effect is concerned, transurethral seminal vesicle surgery is superior to conservative comprehensive therapy, and can be used as a good supplementary treatment for the poor improvement of simple drugs.
【学位授予单位】：中南大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：R697.4
【参考文献】
相关期刊论文 前1条
1 朱峰;张艳;刘沛;张会清;张英杰;;经尿道输尿管镜技术诊治血精28例临床分析[J];中国内镜杂志;2012年09期
，本文编号：2376914
本文链接：https://www.wllwen.com/yixuelunwen/mjlw/2376914.html
最近更新
教材专著
